Persistent Asset Partners LTD Uro Gen Pharma Ltd. Transaction History
Persistent Asset Partners LTD
- $135 Billion
- Q2 2025
A detailed history of Persistent Asset Partners LTD transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Persistent Asset Partners LTD holds 34,600 shares of URGN stock, worth $700,650. This represents 0.35% of its overall portfolio holdings.
Number of Shares
34,600
Previous 17,571
96.92%
Holding current value
$700,650
Previous $194 Million
143.92%
% of portfolio
0.35%
Previous 0.16%
Shares
2 transactions
Others Institutions Holding URGN
# of Institutions
166Shares Held
39.7MCall Options Held
2.06MPut Options Held
717K-
Rtw Investments, LP New York, NY4.54MShares$92 Million0.96% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A63.19MShares$64.6 Million0.08% of portfolio
-
Morgan Stanley New York, NY2.48MShares$50.2 Million0.0% of portfolio
-
Jefferies Financial Group Inc. New York, NY2.2MShares$44.5 Million0.27% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$44.4 Million0.0% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $460M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...